We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Braveheart Investment Group Plc | LSE:BRH | London | Ordinary Share | GB00B13XV322 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 3.85% | 6.75 | 6.50 | 7.00 | 6.75 | 6.50 | 6.50 | 301,258 | 11:12:35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Management Services | 51k | 1.59M | 0.0249 | 2.71 | 4.3M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/5/2020 08:03 | Utter small time trash £80k pmsl All the worst penny share pump and dump crew involved | the stigologist | |
04/5/2020 08:01 | Dave, what part will BRH's Paraytec play for Aptamer? Using our aptamer platform, in conjunction with lateral flow technology, we can develop a reagent rapidly and have a proof of concept, point of care test ready for scale up with the right partner. But we cannot do this alone, we are actively looking for LFD manufacturers and channel partners to help turn our reagents into finalized products. At Aptamer Group Ltd, our scientists are continuously working to develop an aptamer binder selective for the spike protein in SARS CoV-2 which we expect to complete in 2-3 weeks time. Our aim is to work this into a point-of-use test for the detection of virus itself, and have a proof-of-concept in two months. Please contact us using the form below if you would like more information and if this is something that you’d like to get involved in. | euclid5 | |
04/5/2020 07:51 | Probably be a few more rns this week of increased stakes or injections of capital into various investments. | dave4545 | |
04/5/2020 07:48 | This looks excellent news on the surface. | 1savvyinvestor | |
04/5/2020 07:22 | 🤔 loan conversion at Kirkstall, BRH now own 80%. | bumpa33 | |
03/5/2020 22:52 | Big week ahead this is still so under the radar one of the most obvious Covid multibag opportunities along with ODX IMO | saw89 | |
03/5/2020 21:00 | This project brings together the innovative detection technology of Paraytec Ltd with the target recognition technology provided by Aptamer Diagnostic Ltd to create the next generation of detection instruments. These novel platforms will allow rapid field and point-of-care diagnosis based on multiplex detection of markers of disease or contamination. Simultaneous detection of multiple markers will reduce the ambiguity associated with diagnostic systems which look for single markers. It will also save both time and expense associated with routine laboratory based sample screening, allowing them to focus on samples where more detailed analysis is required. | euclid5 | |
03/5/2020 20:59 | Overall, aptamers could provide a strong tool for the expansion of new diagnostic and therapeutic factors in virus infections with negligible side effects as compared to traditional antibodies. Since the outbreak of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus, this disease has spread rapidly around the globe. The poor clinical outcome proves the high severity of the disease. At, Aptamer Group Ltd, our scientists are continuously working to develop an aptamer binder selective for the spike protein in SARS CoV-2 which we expect to complete in 3-4 weeks. Our aim is to work this into a point-of-use test for the detection of virus itself, and have a proof-of-concept in two months. | euclid5 | |
03/5/2020 20:56 | Shortened development time for developing a rapid Point of Care COVID-19 test At Aptamer Group, we utilise state-of-the-art in-vitro techniques to rapidly isolate nucleic acid sequences (aptamers), that are engineered to bind with high selectivity to a variety of targets. These include, but are not limited to, proteins, small molecules, whole cells and even whole organisms; therefore, we can employ aptamers in the fight against COVID-19. Aptamers are commonly referred to as chemical antibodies; however, aptamers are quicker to develop and inexpensive to synthesize meaning we can develop tests, faster and more cost effectively, allowing us to get them into the hands of people who need them sooner! THE ISSUE As the COVID-19 pandemic continues, one of the key challenges is the ability to test rapidly for the virus. The DHSC states: “The ramping up of testing will include developing a point-of-care swab test, outside of hospitals, so people with suspected symptoms can quickly find out if they have coronavirus. We have called on industry to rapidly develop this test”. THE SOLUTION Using our aptamer platform, in conjunction with lateral flow technology, we can develop a reagent rapidly and have a proof of concept, point of care test ready for scale up with the right partner. But we cannot do this alone, we are actively looking for LFD manufacturers and channel partners to help turn our reagents into finalized products. | euclid5 | |
03/5/2020 19:01 | Can see recent highs 40p breaking Mon / Tue | saw89 | |
03/5/2020 14:45 | like realistically how much is this worth if they announce a covid test? | stockhunters | |
02/5/2020 22:05 | Further Placing to raise GBP350,000Braveheart Investment Group (AIM: BRH), is pleased to announce that, further to the announcement on 29 April 2020 and following significant demand from investors in the last two day.He stated investors which implies more than one obviously but I saw something on twitter saying he was approached by a big investor apparently but who knows. I'm holding to find out what the money was needed exactly for, hopefully an update this week mate. Best of luck. | bluearmy1 | |
01/5/2020 18:54 | look fwd to the rns holding news then - how do you know it went to just one investor? | euclid5 | |
01/5/2020 18:19 | sticky money great news when rns lands | stockhunters | |
01/5/2020 16:41 | Notice how they offered the wrts at 40p and not near the placing price - must be confident on getting their | euclid5 | |
01/5/2020 15:06 | Sorry repeat of the other day. N/T to buy at 26p now...the fast buck merchants will be trying to get back in | dave4545 | |
01/5/2020 15:02 | Ding Ding Round 2. | awise355 | |
01/5/2020 14:56 | We might see a mini repeat of last week...could get to 30-35p...if it does 35-40p again that would be a bonus...and I would slice some again that I bought back last few days :-)) | dave4545 | |
01/5/2020 14:44 | Excellent. | awise355 | |
01/5/2020 14:19 | 2Prsimo - just checked the 227k print, it is today and not delayed either | bumpa33 | |
01/5/2020 14:18 | haha sellers this morning | stockhunters | |
01/5/2020 14:15 | 24-24p cannot buy book flip mm's lapped up all the panic sellers, who sells below a placing and a strong one anyway ? | dave4545 | |
01/5/2020 14:10 | 23/24 ain’t the right price. | bumpa33 | |
01/5/2020 14:06 | Can get naff all online - yes that's Hargreaves!! | 2prsimo | |
01/5/2020 13:59 | Big buy just printed - 227,000 at 26.00p. That's not chicken feed | 2prsimo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions